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Lushington
which was a more tolerant state than Virginia,
and stayed active in civic affairs most of his life.
Dr. Lushington faced tremendous odds to
become and practice as a veterinarian. His suc-
cess can be measured in many ways. He was a
veterinary doctor, and a parole officer, and a
federal meat inspector. His community connec-
tions were strong: as a Mason, a deacon, and a
member of the Chamber of Commerce. It was
evident from spending time with Mrs. Moutrie
that he was a wonderful, loving father who
raised and educated two daughters, both of
whom went on to prominence in the field of
education.
Dr. Lushington and Dr. Lewis were at the
forefront of the American veterinary profes-
sion, a field that is constantly changing. Until
World War I, veterinarians were all men, and
worked on large animals primarily. Today, the
patients are predominantly pets, and women
dominate veterinary classrooms. Over time, dif-
ferent animals and different animal diseases
have changed how vets use their time and
expertise. The Penn Veterinary School has sur-
vived these changes, which is an amazing eco-
nomic feat. Penn’s administration is a model of
tolerance, and there are support centers for stu-
dents in crisis. The School has learned that
alumni veterinarians will stay connected to
Penn throughout their lives if their school
experience has been welcoming and positive.
The School has reached out to embrace its
past in many ways. One example is through the
gallery of photographs in the lobby of the
Gladys Hall Rosenthal Building. Some photos
depict century-old veterinary classes, profes-
sors, and buildings. Occupying a prominent
space in the lobby gallery is a black-and-white
photograph from the 1890s of a well-dressed,
bespectacled young man—the picture of Dr.
Lushington that I first saw on the Internet.
With the placement of his photograph in the
lobby, Dr. Lushington, one of our most distin-
guished alumni, now welcomes all who enter
our School.
Alice S. Weiss, V’84, is a veterinary medical
officer at the FDA and a writer in Bethesda, Md.
by Steve Bradt
Scientists at the School have found a novel
way to boost the paltry survival rate of cloned
mammals: When two genetically identical
cloned mouse embryos are combined, the
aggregate embryo is considerably more likely
to survive to birth.
The team reported the results in the
October 1 issue of the European Molecular
Biology Organization Journal.
“At the blastocyst stage, an early embryonic
stage just prior to implantation, mouse clones
typically have a much lower than normal
number of cells,” says corresponding author
K. John McLaughlin, Ph.D., assistant professor
of Reproductive Physiology. “When we com-
bined two clones at the four-cell stage, the
embryos showed a remarkable improvement
in viability, much greater than expected from
the sum of their parts.”
Despite the successful cloning of sheep,
pigs, cats, and most recently rats, mammalian
cloning—in which an ordinary cell’s nucleus is
transferred to an egg whose nucleus has been
removed—remains remarkably inefficient. Of
every 100 cloned mice, roughly one survives to
birth.
The researchers found that when the clone
hybrids were transferred back into the uteri of
recipient mice, the survival rate jumped to 8
percent. The researchers even produced a litter
of four cloned mouse pups, in stark contrast
to the typical single pup born.
Cloning requires the precise genetic repro-
gramming of the nucleus inserted into an enu-
cleated egg. This nucleus must abandon its
former genetic program and adopt the genetic
Improving Survival Rate of Cloned Mouse Embryos
Pfizer Animal Health Gift
Pfizer Animal Health donated funds for
the purchase of a plasma screen to be
installed in one of the School’s
Multidisciplinary Laboratories. This will
greatly enhance the teaching of histology
and histopathology during rounds as
images can be projected onto the screen
from a microscope. These images are
superior to those seen through a multihead
scope and will provide students with more
information.
profile of an embryonic nucleus; failure to do so
dooms the embryo.
“The paper provides a new insight into
reprogramming following nuclear transfer,” says
Davor Solter, a developmental biologist at the
Max-Planck Institute of Immunobiology who
was not involved in this work. “It confirms indi-
rectly that every cloned embryo is actually differ-
ent and that reprogramming is random. It seems
that two embryos that are epigenetically different
can positively interact and complement each
other, leading to correct temporal and spatial
gene expression. That this type of interaction
can take place was not obvious and it could only
be demonstrated by the described approach.”
McLaughlin and his colleagues are not yet
sure why the aggregation of cloned embryos
boosts survival, although one theory is that the
combination of two embryos helps compensate
for genetic deficiencies in either.
“The genetic reprogramming of a cloned
embryo never seems to occur with 100 percent
accuracy,” McLaughlin says. “However, the group
of genes that fails to reset properly differs in each
individual embryo, meaning that each embryo
that contributes to an aggregate can help mask
the shortcomings of the other. By combining
cloned embryos, you might end up with an
embryo that’s 99 percent reprogrammed rather
than just 90 percent.”
When McLaughlin and colleagues cut wild-
type mouse embryos in half, they found that the
expression of key developmental genes was not
affected, suggesting that the developmental defi-
ciencies of cloned embryos are not due to low
cell counts alone. They speculate that cells in a
blastocyst may communicate in a way that is
compromised in a smaller cloned embryo.
McLaughlin’s coauthors for the EMBO
Journal paper include Drs. Michele Boiani,
Sigrid Eckardt, N. Adrian Leu, and Hans R.
Schöler—all of Penn’s Center for Animal
Transgenesis and Germ Cell Research. Their
work was funded by the Marion Dilley and
David George Jones Funds, the Commonwealth
and General Assembly of Pennsylvania, the
National Institutes of Health, the University of
Pennsylvania Research Foundation, and the
United States Department of Agriculture.
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